Ethyl docosa-4,7,10,13,16,19-hexaenoate
CAS No. 84494-72-4
Ethyl docosa-4,7,10,13,16,19-hexaenoate( —— )
Catalog No. M33600 CAS No. 84494-72-4
Ethyl cis-4,7,10,13,16,19-Docosahexaenoate, the ethyl ester of Docosahexaenoate (DHA), is selectively enriched in the ethyl ester fraction through alcoholysis using fatty acid ethyl esters from tuna oil and lauryl alcohol.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 32 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 75 | In Stock |
|
| 1G | 110 | In Stock |
|
Biological Information
-
Product NameEthyl docosa-4,7,10,13,16,19-hexaenoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEthyl cis-4,7,10,13,16,19-Docosahexaenoate, the ethyl ester of Docosahexaenoate (DHA), is selectively enriched in the ethyl ester fraction through alcoholysis using fatty acid ethyl esters from tuna oil and lauryl alcohol.
-
DescriptionEthyl cis-4,7,10,13,16,19-Docosahexaenoate, the ethyl ester of Docosahexaenoate (DHA), is enriched in the ethyl ester fraction by the selective alcoholysis of fatty acid ethyl esters originating from tuna oil with lauryl alcohol.
-
In VitroEthyl cis-4,7,10,13,16,19-Docosahexaenoate (Ethyl docosahexaenoate; E-DHA) is efficiently enriched by the selective alcoholysis of ethyl esters originating from tuna oil with lauryl alcohol using immobilized lipase.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number84494-72-4
-
Formula Weight356.54
-
Molecular FormulaC24H36O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (280.47 mM; Ultrasonic)DMSO : 100 mg/mL (280.47 mM; Ultrasonic )
-
SMILESC(=CCC=CCC=CCC=CCC=CCC=CCC)CCC(OCC)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yuji Shimada, et al. Purification of ethyl docosahexaenoate by selective alcoholysis of fatty acid ethyl esters with immobilized Rhizomucor miehei lipase. J Am Oil Chem Soc. 1998 Nov, 75(11): 1565–1571.
molnova catalog
related products
-
Hexaminolevulinate h...
Hexaminolevulinate hydrochloride has approved for cystoscopic detection of papillary bladder cancer and it also is a fluorescent agent.
-
PKG drug G1
PKG drug G1 targets C42 of PKG Iα. PKG drug G1 can couple to vasodilation and blood pressure lowering by a C42 PKG Iα-independent mechanism.
-
13(S)-Hydroxyoctadec...
(±)13-HODE is one of the two racemic monohydroxy fatty acids resulting from the non-enzymatic oxidation of linoleic acid.
Cart
sales@molnova.com